|
1
|
Forty-eight-hour fast: the diagnostic test for insulinoma.
|
J Clin Endocrinol Metab
|
2000
|
2.75
|
|
2
|
Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study.
|
Ann Intern Med
|
1995
|
2.74
|
|
3
|
Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium.
|
Ann Intern Med
|
1995
|
2.05
|
|
4
|
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
|
J Clin Endocrinol Metab
|
1999
|
1.92
|
|
5
|
Somatic mutation of the MEN1 gene in parathyroid tumours.
|
Nat Genet
|
1997
|
1.90
|
|
6
|
Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
|
Cancer Res
|
1997
|
1.82
|
|
7
|
Multiple endocrine neoplasia type 1: clinical and genetic topics.
|
Ann Intern Med
|
1998
|
1.81
|
|
8
|
Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
|
Hum Mol Genet
|
1997
|
1.77
|
|
9
|
MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy.
|
J Clin Endocrinol Metab
|
1997
|
1.68
|
|
10
|
Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.
|
J Clin Endocrinol Metab
|
1998
|
1.56
|
|
11
|
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells.
|
J Clin Endocrinol Metab
|
2001
|
1.54
|
|
12
|
Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.
|
Arch Dermatol
|
1997
|
1.53
|
|
13
|
Parathyroid adenomas in the aortopulmonary window.
|
Radiology
|
1996
|
1.46
|
|
14
|
Multiple endocrine neoplasia type 1: new clinical and basic findings.
|
Trends Endocrinol Metab
|
2001
|
1.36
|
|
15
|
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
|
Recent Prog Horm Res
|
1999
|
1.29
|
|
16
|
The impact of age and gender on papillary thyroid cancer survival.
|
J Clin Endocrinol Metab
|
2012
|
1.25
|
|
17
|
Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health.
|
J Clin Endocrinol Metab
|
1999
|
1.14
|
|
18
|
Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.
|
Surgery
|
2001
|
1.11
|
|
19
|
False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst.
|
J Nucl Med
|
1996
|
1.10
|
|
20
|
Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas.
|
Surgery
|
1997
|
1.10
|
|
21
|
Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
|
Cancer Res
|
1997
|
1.08
|
|
22
|
Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach.
|
Hum Pathol
|
1995
|
1.08
|
|
23
|
Results of heterotopic parathyroid autotransplantation: a 13-year experience.
|
Surgery
|
1999
|
1.04
|
|
24
|
Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
|
J Clin Endocrinol Metab
|
2000
|
1.04
|
|
25
|
Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone.
|
J Clin Endocrinol Metab
|
1996
|
1.03
|
|
26
|
Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.
|
Am J Pathol
|
2001
|
0.99
|
|
27
|
Operative management of islet-cell tumors arising in the head of the pancreas.
|
Surgery
|
1998
|
0.94
|
|
28
|
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas.
|
Surgery
|
2000
|
0.92
|
|
29
|
Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism.
|
J Nucl Med
|
1995
|
0.89
|
|
30
|
Plasma proinsulin-like component in insulinoma: a 25-year experience.
|
J Clin Endocrinol Metab
|
1995
|
0.89
|
|
31
|
Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism.
|
Surgery
|
1994
|
0.89
|
|
32
|
Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii.
|
J Clin Endocrinol Metab
|
2000
|
0.89
|
|
33
|
Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant.
|
J Clin Endocrinol Metab
|
2001
|
0.87
|
|
34
|
The gene for multiple endocrine neoplasia type 1: recent findings.
|
Bone
|
1999
|
0.85
|
|
35
|
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
|
Hum Mutat
|
1998
|
0.85
|
|
36
|
Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism.
|
Surgery
|
1994
|
0.84
|
|
37
|
Repaglinide-induced factitious hypoglycemia.
|
J Clin Endocrinol Metab
|
2001
|
0.83
|
|
38
|
Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperparathyroidism.
|
Surgery
|
1993
|
0.83
|
|
39
|
Free alpha molecules from pregnancy stimulate secretion of prolactin from human decidual cells: a novel function for free alpha in pregnancy.
|
Endocrinology
|
1991
|
0.80
|
|
40
|
Levothyroxine replacement therapy in central hypothyroidism: a practice report.
|
Pharmacotherapy
|
1999
|
0.79
|
|
41
|
Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
|
Thyroid
|
2002
|
0.79
|
|
42
|
Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis.
|
Medicine (Baltimore)
|
2000
|
0.78
|
|
43
|
11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
|
Mol Genet Metab
|
1998
|
0.78
|
|
44
|
Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).
|
J Intern Med
|
1998
|
0.77
|
|
45
|
Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course.
|
J Clin Ultrasound
|
1998
|
0.76
|
|
46
|
High cervical intravagal hypercellular parathyroid gland as the etiology of severe persistent primary hyperparathyroidism.
|
Am Surg
|
1995
|
0.75
|
|
47
|
Effectiveness of long-acting octreotide in suppressing hormonogenesis and tumor growth in thyrotropin-secreting pituitary adenomas: report of two cases.
|
Pituitary
|
2001
|
0.75
|
|
48
|
Hypocalcemic stimulation and nonselective venous sampling for localizing parathyroid adenomas: work in progress.
|
Radiology
|
1998
|
0.75
|
|
49
|
Parathyroid adenoma within the vagus nerve.
|
AJR Am J Roentgenol
|
1994
|
0.75
|
|
50
|
Tc-99m sestamibi imaging of a hyperfunctioning parathyroid autograft with Doppler ultrasound and MRI correlation.
|
Clin Nucl Med
|
1995
|
0.75
|
|
51
|
[TSH-secreting pituitary adenoma: 16 years follow-up].
|
Med Klin (Munich)
|
2000
|
0.75
|
|
52
|
Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.
|
J Endocrinol Invest
|
2000
|
0.75
|